Biocon's Itolizumab approved as life-saving COVID-19 medicine; Kiran Mazumdar-Shaw announces details
India | Jul 13, 2020, 03:17 PM ISTKiran Mazumdar Shaw, the Executive Chairperson of Biocon Limited, announced Monday that it has received the Drugs Controller General of India’s (DCGI) approval to market Itolizumab (ALZUMAb) Injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome (CRS) in moderate to severe ARDS (acute respiratory distress syndrome) patients due to COVID-19.